You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia,%20Myeloid,%20Chronic-Phase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

Not yet recruiting
  • Chronic Myelogenous Leukemia - Chronic Phase
  • APN and medical management
  • +3 more
  • Avignon, Provence-Alpes-Côte d'Azur, France
    Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
Oct 13, 2023

CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

Recruiting
  • CML, Chronic Phase
  • CML, Accelerated Phase
  • HS-10382(Part 1: Dose escalation)
  • HS-10382(Part 2: Dose expansion)
  • Wuhan, Hubei, China
    Union Hospital affiliated to Tongji Medical College of Huazhong
Jan 12, 2023

Metabolic Alternation and Clinicohematological Characteristic in

Not yet recruiting
  • CML, Chronic Phase
  • Tyrosine kinase inhibitor
  • (no location specified)
Nov 6, 2023

Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 11, 2022

Leukemia, Acute Myeloid Leukemia in Remission, Myelodysplasia Trial (Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi))

Not yet recruiting
  • Leukemia
  • +12 more
  • Magnetic-Activated Cell Sorter (CliniMACS, Miltenyi)
  • (no location specified)
Mar 20, 2023

New Diagnosed Chronic Phase Chronic Myeloid Leukemia

Recruiting
  • Validity and Safety
    • Guangzhou, Guangdong, China
      NanfangH
    Apr 9, 2022

    Myeloproliferative Tumor, Chronic Phase Chronic Myelogenous Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (Online

    Recruiting
    • Myeloproliferative Neoplasm
    • +2 more
    • Online Mindfulness Meditation
    • Internet-Based Webinars
    • San Francisco, California
      University of California San Francisco
    Aug 9, 2022

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +2 more
    • Laboratory Biomarker Analysis
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 15, 2022

    CML, Chronic Phase Trial in Harbin (Flumatinib, Imatinib)

    Not yet recruiting
    • CML, Chronic Phase
    • Harbin, Heilongjiang, China
      Institute of Hematology and Oncology, Harbin The First Hospital
    May 5, 2022

    Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

    Completed
    • Chronic Myeloid Leukemia
      • East Hanover, New Jersey
        Novartis
      Nov 20, 2023

      Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous

      Recruiting
      • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • +6 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 31, 2022

      Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Phase Chronic Myelogenous Leukemia Trial in Philadelphia (Text

      Recruiting
      • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
      • Chronic Phase Chronic Myelogenous Leukemia
      • Text Message-Based Navigation Intervention
      • Survey Administration
      • Philadelphia, Pennsylvania
        Sidney Kimmel Cancer Center at Thomas Jefferson University
      Apr 7, 2022

      Ponatinib in CML Patients in Chronic Phase

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Therapeutic drug monitoring
      • Molecular Response
      • Cagliari, Italy
      • +4 more
      Nov 3, 2023

      CML, Chronic Phase Trial in Harbin (Flumatinib mesylate tablets (400mg), Flumatinib mesylate tablets (600mg))

      Recruiting
      • CML, Chronic Phase
      • Flumatinib mesylate tablets (400mg)
      • Flumatinib mesylate tablets (600mg)
      • Harbin, Hei Longjiang, China
        Institute of Hematology and Oncology, Harbin The First Hospital
      Apr 28, 2022

      Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

      Active, not recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
        • Jena, Germany
          University Hospital Jena
        Jan 17, 2023

        Chronic Phase Chronic Myelogenous Leukemia Trial in Detroit, Milwaukee (Asciminib, Imatinib)

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia
        • Detroit, Michigan
        • +1 more
        May 3, 2022

        Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic

        Recruiting
        • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia
        • Houston, Texas
          M D Anderson Cancer Center
        Jun 24, 2022

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

        Completed
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +4 more
        • Eltrombopag Olamine
        • Houston, Texas
          M D Anderson Cancer Center
        Jan 4, 2022

        Leukemia, Myeloid, Chronic-Phase Trial in Germany (Ponatinib)

        Active, not recruiting
        • Leukemia, Myeloid, Chronic-Phase
        • Halle (Saale), Saxony-Anhalt, Germany
        • +9 more
        Sep 9, 2022

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in

        Active, not recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +11 more
        • Duarte, California
          City of Hope Medical Center
        Dec 8, 2022

        Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

        Recruiting
        • Chronic Myeloid Leukemia in Myeloid Blast Crisis
        • +3 more
        • based decitabine and olverembatinib（HQP1351)chemotherapy
        • Guanzhou, China
          Department of Hematology, Nanfang Hospital, Southern Medical Uni
        Dec 6, 2022

        MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

        Not yet recruiting
        • Myelodysplastic Syndromes
        • +3 more
        • Subcutaneous azacitidine
        • Oral decitabine/cedazuridine
        • Newcastle, New South Wales, Australia
          Calvary Mater Newcastle
        May 29, 2023

        Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

        Terminated
        Has Results
        • Chronic Phase Chronic Myeloid Leukemia
        • Ponatinib 30 mg QD
        • +2 more
        • Bruxelles, Belgium
          Cliniques Universitaire Saint-Luc (Site 058)
        Oct 28, 2021

        Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute

        Active, not recruiting
        • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
        • +13 more
        • CMVpp65-A*0201 peptide vaccine
        • +2 more
        • Duarte, California
        • +4 more
        Jan 4, 2023

        CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

        Recruiting
        • CML
        • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
        • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
          FUNDALEU
        Jun 29, 2023